Trial reportSleep2025
Is sleep compression therapy non-inferior to sleep restriction therapy? A single-blind randomized controlled non-inferiority trial comparing sleep compression therapy to sleep restriction therapy as treatment for insomnia.
Trial report in Sleep, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02743338 (CompRest - a Randomized Comparison Between Sleep Compression and Sleep Restriction for the Treatment of Insomnia), which is not on this map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
CompRest - a Randomized Comparison Between Sleep Compression and Sleep Restriction for the Treatment of Insomnia
Who cites it
4 citing papers in PubMed.
- The Adherence Conundrum of Sleep Restriction Therapy for Insomnia.Journal of sleep research · 2026Trial
- Article
- A mixed-method process evaluation of guided online cognitive behavioral therapy for insomnia in patients with borderline personality disorder.BMC psychiatry · 2026Article
- The noninferiority complex: abrupt versus gradual restriction of time in bed for insomnia disorder.Sleep · 2025Article
Corrections and comments
- Commented on by
Authors and funding
9 authors.
Funding
Abstract
STUDY
objectivesInsomnia disorder, affecting 10% of the population, poses a significant public health concern and is a risk-factor for many health issues. Cognitive behavioral therapy is first-choice treatment, but the key component-sleep restriction therapy-presents with side effects and adherence challenges. Sleep compression therapy, suggested as a potentially gentler alternative, has never been directly compared to sleep restriction therapy.
methodsSingle-blind trial at the Internet Psychiatry Clinic in Stockholm, Sweden. Patients with insomnia disorder were randomized 1:1 to evaluate non-inferiority of sleep compression therapy to sleep restriction therapy in improving insomnia and to compare important clinical aspects. Primary outcome: self-reported Insomnia Severity Index (ISI), assessed pretreatment, weeks 1-5, and week 10. Non-inferiority analysis based on intent-to-treat analyses with multiple imputation and mixed effects models.
resultsAdults with insomnia (n = 234; mean age 44.3 [SD = 13.7] years, 173 [73.4%] female) received treatment as a 10-week highly structured, therapist-guided online program, to strengthen experimental integrity and treatment fidelity. Both treatments improved insomnia severity with large effects. Sleep compression therapy failed to show non-inferiority with a conservative limit of 1.6 ISI-points (95% CI: -0.01, 1.70), gave statistically significantly smaller improvements (p = .006), and was associated with slower improvements despite better adherence and somewhat less side effects.
conclusionsThis direct comparison and well-controlled trial provides empirically based support for clinicians to prioritize sleep restriction therapy over sleep compression therapy, while the latter can be a valid alternative when sleep restriction therapy cannot be used. CLINICAL TRIAL: CompRest-a Comparison Between Sleep Compression and Sleep Restriction for Treating Insomnia. URL: https://clinicaltrials.gov/study/NCT02743338?term=NCT02743338&rank=1. REGISTRATION: NCT02743338.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.